Logo image of OZ

BELPOINTE PREP LLC (OZ) Stock Fundamental Analysis

NYSEARCA:OZ - NYSE Arca - US0806941029 - Common Stock - Currency: USD

66.53  +0.37 (+0.55%)

Fundamental Rating

1

Overall OZ gets a fundamental rating of 1 out of 10. We evaluated OZ against 65 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of OZ have multiple concerns. OZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year OZ has reported negative net income.
OZ had a negative operating cash flow in the past year.
OZ had negative earnings in each of the past 5 years.
In the past 5 years OZ always reported negative operating cash flow.
OZ Yearly Net Income VS EBIT VS OCF VS FCFOZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

OZ has a Return On Assets (-5.30%) which is comparable to the rest of the industry.
OZ's Return On Equity of -9.71% is in line compared to the rest of the industry. OZ outperforms 47.69% of its industry peers.
Industry RankSector Rank
ROA -5.3%
ROE -9.71%
ROIC N/A
ROA(3y)-3.51%
ROA(5y)-2.35%
ROE(3y)-4.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZ Yearly ROA, ROE, ROICOZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40 60 80 100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZ Yearly Profit, Operating, Gross MarginsOZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

0

2. Health

2.1 Basic Checks

OZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OZ has been increased compared to 1 year ago.
The debt/assets ratio for OZ is higher compared to a year ago.
OZ Yearly Shares OutstandingOZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
OZ Yearly Total Debt VS Total AssetsOZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

OZ has a Debt/Equity ratio of 0.70. This is a neutral value indicating OZ is somewhat dependend on debt financing.
OZ has a Debt to Equity ratio (0.70) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.78%
OZ Yearly LT Debt VS Equity VS FCFOZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

OZ has a Current Ratio of 0.80. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.80, OZ is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
OZ has a Quick Ratio of 0.80. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
OZ's Quick ratio of 0.80 is on the low side compared to the rest of the industry. OZ is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
OZ Yearly Current Assets VS Current LiabilitesOZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for OZ have decreased strongly by -80.07% in the last year.
Looking at the last year, OZ shows a very strong growth in Revenue. The Revenue has grown by 94.70%.
OZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.96% yearly.
EPS 1Y (TTM)-80.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.48%
Revenue 1Y (TTM)94.7%
Revenue growth 3Y38.96%
Revenue growth 5YN/A
Sales Q2Q%416.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OZ Yearly Revenue VS EstimatesOZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

4. Valuation

4.1 Price/Earnings Ratio

OZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZ Price Earnings VS Forward Price EarningsOZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OZ Per share dataOZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELPOINTE PREP LLC

NYSEARCA:OZ (6/12/2025, 8:19:57 PM)

66.53

+0.37 (+0.55%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners37.64%
Inst Owner Change-4.94%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap252.15M
Analysts0
Price TargetN/A
Short Float %1.67%
Short Ratio5.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.85
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-7.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-35.41
FCFYN/A
OCF(TTM)-3.61
OCFYN/A
SpS1.08
BVpS77.42
TBVpS77.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.3%
ROE -9.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.51%
ROA(5y)-2.35%
ROE(3y)-4.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1590.29%
Cap/Sales 2956.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z N/A
F-Score3
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)4896.45%
Cap/Depr(5y)18197.1%
Cap/Sales(3y)5462.86%
Cap/Sales(5y)10108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)94.7%
Revenue growth 3Y38.96%
Revenue growth 5YN/A
Sales Q2Q%416.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-390.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.27%
OCF growth 3YN/A
OCF growth 5YN/A